Skip to main content

Table 5 Locoregional recurrence within HR-/HER2- subtype by presence of lymphovascular invasion (LVI) (Number = 80)

From: Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy

Variable Locoregional recurrence No recurrence LRR probability at 60 month P-value
LVI positive 4 12 29.7%  
LVI negative 6 58 9.2% 0.04